ESTRO 36 will take place 5-9 May 2017 in Vienna, Austria.
ESTRO is an interdisciplinary society where radiation oncologists, medical physicists, radiobiologists, brachytherapists and radiation therapists aspire to join forces with other organisations in the oncology field that share ESTRO’s vision of excellence in cancer treatment. At ESTRO 36, we draw attention to the multidisciplinary and interdisciplinary components of our practice, with emphasis on the new opportunities that they represent for all professionals of oncology, not only in research but also in the daily care of patients.
The interdisciplinary component of the scientific programme will include sessions on the following topics:
• MR guided radiotherapy: the new standard of care in 10 years time
• Radiomics and imaging databases for precision radiation oncology
• From big data to better radiotherapy
• Costs and value of radiotherapy innovations: how to assess
• Challenges in proton radiotherapy
• Is there any ground for boost brachytherapy in the time of high precision IGRT/IMRT?
• Selection of patients and radiotherapy technique for APBI in the light of new phase III trial data
• Clinical evidence for hypofractionation in prostate cancer what is the optimum?
• Oligometastatic disease
• Radiotherapy plus immunotherapy combination: rationale and results so far
• Targeting tumour heterogenveity
• Response adapted treatment
• Patient Reported Outcomes (PROs) in radiotherapy
• Safety and clinical and cost effectiveness of multi-modality IGRT and ART
• Clinical impact of waiting times
• Strategies to increase safety in radiation oncology: how to make accidents less likely to occur
Meanwhile, the Scientific Programme Committee and Scientific Advisory Groups of ESTRO 36 work hard to develop an excellent multidisciplinary component for the scientific programme, a multidisciplinarity which will also be highlighted in several joint sessions with other European and international oncology societies.
The educational aspects of ESTRO 36 will include pre-meeting courses, contouring workshops, teaching lectures and multidisciplinary tumour board sessions.
As in previous conferences, ESTRO 36 will offer a Young Scientists Track. This track is fully organised by our young members and it enables them to meet young colleagues, share common interests, network and start to build their own collaborative projects at an international level.
Last but not least, the ESTRO annual meetings can only become a successful scientific event due to the multitude of contributions coming via abstract submissions. The Scientific Programme Committee is committed to offering large visibility to promising abstracts by including them in the scientific symposia or via dedicated poster viewing sessions. We therefore strongly encourage you to take note of the abstract submission deadline and to send your abstracts in due time.
All of the leading exhibitors will contribute to ESTRO 36, Europe’s largest industrial exhibition in radiation oncology, offering the opportunity to view the latest radiotherapy technology and cancer treatment products.
All information is copied from http://estro.org/congresses-meetings/articles/estro-36-welcome-letter